First Time Loading...

IDEAYA Biosciences Inc
NASDAQ:IDYA

Watchlist Manager
IDEAYA Biosciences Inc Logo
IDEAYA Biosciences Inc
NASDAQ:IDYA
Watchlist
Price: 41.18 USD 1.3% Market Closed
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

IDYA Price Targets Summary
IDEAYA Biosciences Inc

Wall Street analysts forecast IDYA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDYA is 53.96 USD with a low forecast of 50.5 USD and a high forecast of 63 USD.

IDYA Lowest Forecast
Wall Street Target
50.5 USD
23% Upside
IDYA Average Forecast
Wall Street Target
53.96 USD
31% Upside
IDYA Highest Forecast
Wall Street Target
63 USD
53% Upside
Lowest
Price Target
50.5 USD
23% Upside
Average
Price Target
53.96 USD
31% Upside
Highest
Price Target
63 USD
53% Upside
IDEAYA Biosciences Inc Competitors:
Price Targets
ZYME
Zymeworks Inc
70% Upside
MDGL
Madrigal Pharmaceuticals Inc
91% Upside
2256
Abbisko Cayman Ltd
172% Upside
J
600201
Jinyu Bio-Technology Co Ltd
10% Upside
ZYME
Zymeworks Inc
70% Upside
MDGL
Madrigal Pharmaceuticals Inc
91% Upside
2256
Abbisko Cayman Ltd
172% Upside
J
600201
Jinyu Bio-Technology Co Ltd
10% Upside
S
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
38% Upside
ZEAL
Zealand Pharma A/S
22% Upside
ANIK
Anika Therapeutics Inc
17% Upside
C
049960
Cell Biotech Co Ltd
379% Upside

Revenue
Forecast

Revenue Estimate
IDEAYA Biosciences Inc

The compound annual growth rate of IDEAYA Biosciences Inc's revenue for the next 3 years is 56%.

N/A
Past Growth
56%
Estimated Growth
Estimates Accuracy
-13%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
IDEAYA Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
IDEAYA Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss
What are analyst estimates?

See Also

Summary
IDYA intrinsic value, competitors valuation, and company profile.
DCF Valuation
IDYA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IDYA stock valuation using valuation multiples.
Wall Street Estimates
IDYA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IDYA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IDYA's stock price target?
Price Target
53.96 USD

According to Wall Street analysts, the average 1-year price target for IDYA is 53.96 USD with a low forecast of 50.5 USD and a high forecast of 63 USD.

What is IDEAYA Biosciences Inc's Revenue forecast?
Projected CAGR
56%

The compound annual growth rate of IDEAYA Biosciences Inc's revenue for the next 3 years is 56%.

ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.